M Hollmen
Overview
Explore the profile of M Hollmen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms
Hollmen M, Maatta J, Bald L, Sliwkowski M, Elenius K
Oncogene
. 2009 Jan;
28(10):1309-19.
PMID: 19151766
ErbB4 isoforms mediate different cellular activities depending on their susceptibility to proteolytic cleavage. The biological significance of ErbB4 cleavage in tumorigenesis, however, remains poorly understood. Here, we describe characterization of...
2.
Tanner M, Hollmen M, Junttila T, Kapanen A, Tommola S, Soini Y, et al.
Ann Oncol
. 2005 Jan;
16(2):273-8.
PMID: 15668283
Background: HER-2/neu gene amplification has predictive value in breast cancer patients responding to trastuzumab. We wanted to investigate the frequency and clinical significance of HER-2/neu amplification in gastric carcinoma. Patients...
3.
Tuominen O, Hollmen M, Jaakkola O, Monkkonen J, Ylitalo R
Methods Find Exp Clin Pharmacol
. 2002 Dec;
24(8):487-92.
PMID: 12500427
Etidronate and clodronate are bisphosphonates that inhibit the development of experimental atherosclerosis. Etidronate decreases the intimamedia thickness of carotid artery even in man. Liposome-encapsulated bisphosphonates inhibit the cellular metabolism of...